PHILIP DANKYI: Open Payments
NPI 1457351686 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 42 payments from 16 companies in 2025. Trend: 2023 $738 · 2024 $968 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $158 |
| Mallinckrodt Hospital Products Inc. | 2 | $145 |
| Calliditas Therapeutics US Inc. | 6 | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $113 |
| Vantive US Healthcare LLC | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Lilly USA, LLC | 3 | $62 |
| Vifor Pharma, Inc. | 2 | $55 |
| Ardelyx, Inc. | 2 | $46 |
Products named: JARDIANCE, TARPEYO, TERLIVAZ, Vanrafia, Renal - PD, JYNARQUE, Fabhalta, Veltassa.
Industry payments across FL — which companies pay providers there.
